Piper Sandler Reaffirms Ellington With $13 Target
"Piper Sandler reaffirms Ellington Financial as 'Overweight' with a $13 price target, citing strategic acquisitions and robust earnings outlook."
- Latest
- Trending
"Piper Sandler reaffirms Ellington Financial as 'Overweight' with a $13 price target, citing strategic acquisitions and robust earnings outlook."
"Blade & Sorcery Version 1.0 Review: A captivating VR experience with dynamic combat and expansive Sandbox Mode, now enhanced with ...
India's AI sector attracts billions from Amazon, Microsoft, boosting its tech market and leading in data center capacity. AI demand ...
BofA reaffirms Buy rating, $265 target for Zscaler post-Zenith Live 2024, citing strong innovations, strategic shifts, and positive market outlook.
Brighthouse Financial’s stock rating shifted as Piper Sandler cut its price target from $55.00 to $50.00, citing earnings concerns.
Aethir's price could surge by 300% in two weeks due to various factors, while RCOF token sees a presale surge ...
Exploring market manipulation and the evolving nature of meme stocks; questioning if Roaring Kitty has become the new Goliath amidst ...
Israel's start-ups battered by war; 80% affected, 50% struggling with cash. Cukierman's platform offers hope as co-investments falter.
Senate subpoenas Novo's Langa over drug pricing; Jorgensen to testify in September as Novo blames U.S. health system for high ...
Iovance Biotherapeutics has the potential to become a multiproduct company, and even if its stock doesn't soar quickly, it's still ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.